Elicio Therapeutics Cash Flow Statement 2019-2024 | ELTX

Fifteen years of historical annual cash flow statements for Elicio Therapeutics (ELTX).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-35.20$-28.21$-54.57$-80.11$-40.66
$1.17$1.06$2.69$8.29$0.50
$1.39$5.12$25.22$23.16$5.82
$2.56$6.18$27.90$31.45$6.32
$0$0$-0.81$0.44$-0.33
$0$0$0$0$0
$0.02$1.13$-0.87$-5.61$10.71
$-2.30$-0.97$-24.31$27.23$-0.50
$-0.06$-0.15$-25.97$25.77$9.75
$-32.69$-22.18$-52.64$-22.89$-24.59
$-0.03$-0.65$-0.38$-0.04$-0.24
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$-0.03$-0.65$-0.38$-0.04$-0.24
$10.00$0$0.29$32.12$5.27
$0$0$0$0$0
$10.00$0$0.29$32.12$5.27
$6.98$0.08$109$0.28$-0.38
$6.98$21.20$109$20.33$-0.38
$0$0$0$0$0
$21.64$0$-2.46$-0.04$0
$38.61$21.20$107$52.41$4.89
$5.89$-1.63$54.15$29.04$-19.94
$1.18$0.58$12.04$4.72$3.34
$0$0$0$0$0